Cargando…

Biomarkers for Hepatocellular Carcinoma

The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains challenging. Increased understanding of cancer biology and technological advances have enabled identification of a multitude o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behne, Tara, Copur, M. Sitki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357951/ https://www.ncbi.nlm.nih.gov/pubmed/22655201 http://dx.doi.org/10.1155/2012/859076

Ejemplares similares

What Is the Optimal Dose and Schedule for Dasatinib in Chronic Myeloid Leukemia: Two Case Reports and Review of the Literature
por: Jamison, Caroline, et al.
Publicado: (2016)

Radiation Recall Pneumonitis During Systemic Treatment With Everolimus
por: Clark, Douglas, et al.
Publicado: (2015)

Biomarkers for Hepatocellular Carcinoma
por: Lou, Jiatao, et al.
Publicado: (2017)

Models of Hepatocellular Carcinoma and Biomarker Strategy
por: Bagi, Cedo M., et al.
Publicado: (2010)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Normalization of Elevated Tumor Marker CA27-29 After Bilateral Lung Transplantation in a Patient With Breast Cancer and Idiopathic Pulmonary Fibrosis
por: Copur, Mehmet Sitki, et al.
Publicado: (2018)

An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma
por: Abu El Makarem, Mona
Publicado: (2012)

DNA methylation: potential biomarker in Hepatocellular Carcinoma
por: Mah, Way-Champ, et al.
Publicado: (2014)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma
por: Chauhan, Ranjit, et al.
Publicado: (2016)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
por: Omar, Mona A., et al.
Publicado: (2023)

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
por: Hayes, C. Nelson, et al.
Publicado: (2016)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019)

Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers
por: Tai, David, et al.
Publicado: (2019)

Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
por: Pan, Yasi, et al.
Publicado: (2020)

Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
por: Ao, Huang, et al.
Publicado: (2021)

Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace
por: Pocino, Krizia, et al.
Publicado: (2022)

Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
por: Deng, Kaige, et al.
Publicado: (2023)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery
por: Shen, Eric Yi-Liang, et al.
Publicado: (2023)

Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
por: Kimhofer, T, et al.
Publicado: (2015)

Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
por: Marra, Monica, et al.
Publicado: (2011)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas
por: Anwar, Sumadi Lukman, et al.
Publicado: (2015)

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
por: Li, Limin, et al.
Publicado: (2014)

Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
por: Balaceanu, Lavinia Alice
Publicado: (2019)

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
por: Piñero, Federico, et al.
Publicado: (2020)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021)

Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
por: Sorop, Andrei, et al.
Publicado: (2021)

Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
por: Yao, Min, et al.
Publicado: (2022)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma
por: Yao, Min, et al.
Publicado: (2014)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Biomarkers for hepatocellular cancer
por: Singh, Gurjot, et al.
Publicado: (2020)

Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma
por: Grizzi, Fabio, et al.
Publicado: (2007)

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013)

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vdkin0hqrl5dqkaoeldhqav1qh